Trump administration asks the court to reject the case of the abortion pill

The Trump governance asked a federal court on Monday to dismiss a lawsuit that greatly reduces access to the abortus pill Mifepristone -take the same function as the Biden administration in a closely monitoring affiliated case with large implications for access to abortion.

The court that is striking by the Ministry of Justice is striking, since President Trump and a number of officials in his administration strongly oppose abortion rights. Mr Trump often claims that he has appointed three of the judges of the Supreme Court who voted in 2022 to cancel the national right to abortion. And so far, his administration has taken steps in his second term to restrict programs that support reproductive health.

The court application was the first time that the Trump government has weighed the lawsuit, which tries to turn countless legal changes That the Food and Drug Administration, from 2016, which has considerably expanded access to Mifepristone.

The request of the Trump administration did not report the merits of the case, which have not yet been considered by the courts. On the contrary, following the argument that the Biden administration took place shortly before Mr. Trump took office, the court claims that the case does not meet the legal standard that must be heard in the federal court in which it was submitted.

The claimants in the case are the conservative lawyers -general of three states: Missouri, Idaho and Kansas, and the case was submitted to a federal court in Texas.

“The states do not dispute that their claims are not related to the Northern district of Texas,” wrote the Ministry of Justice’s lawyers in the submission.

“Regardless of the benefits of the claims of the States, the States cannot continue in this court,” they conclude, adding that the complaint “must be rejected or transferred due to a lack of location.”

The lawsuit also requires new FDA restrictions on Mifepistone, including to ban the medication for everyone under the age of 18. And it is aimed at the fast -growing practice of prescribing abortion pills via telegeniatrics and emailing them to patients, including those in states with an abortion ban.

The case was initially submitted in 2022 by a consortium of anti-abortion doctors and groups and discovered for the Supreme Court. But in unanimous ruling last June, the judges threw the case away and said the claimants didn’t stand To sue because they could not prove that they had caused damage due to the FDA’s decisions about Mifepistone.

A few months later, the three lawyers general new life And submitted a changed complaint as plaintiffs at the same federal court in Texas. The judge in the case, judge Matthew J. Kacsmaryk of the American court for the Northern district of Texas, a Trump appointed opposes abortic accessstatements in the first iteration of the case that the FDA indeed criticized and much of the Terminology used by anti-abortion activists.

Abortus pills are prescribed for up to 12 weeks in pregnancy in the United States and are now used in nearly two -thirds of the abortions in the country. Women in states with abortion prohibitions have increasingly searched for abortion pills through counting medicine providers.

Currently, 19 States Have prohibited or limitations stricter than the standard set by Roe v. Wade. In states that support abortion rights, providers of counting medicine abortion have been expanded and a number of states have elapsed shield laws Those doctors and other healthcare providers protect those abortion pills and send to patients in states with prohibitions or limitations.